References

A newly discovered human pneumovirus isolated from young children with respiratory tract disease

10.1038/89098 · 2001 · External reference

Asymptomatic shedding of respiratory virus among an ambulatory population across seasons

10.1128/msphere.00249-18 · 2018 · External reference

Clinical significance of human metapneumovirus detection in critically ill adults with lower respiratory tract infections

10.1186/s13613-023-01117-w · 2023 · External reference

Unresolved reference

2025 · External reference

Receptors and host factors: key players in human metapneumovirus infection

10.3389/fcimb.2025.1557880 · 2025 · External reference

Human metapneumovirus infection among family members

10.1017/s095026881200129x · 2013 · External reference

Incubation periods of acute respiratory viral infections: a systematic review

10.1016/s1473-3099(09)70069-6 · 2009 · External reference

Current insights into respiratory virus transmission and potential implications for infection control programs : a narrative review

10.7326/m21-2780 · 2021 · External reference

Testing and masking policies and hospital-onset respiratory viral infections

10.1001/jamanetworkopen.2024.48063 · 2024 · External reference

Human metapneumovirus circulation and seasonality on a global scale, 2016–2025: Changes in patterns and epidemic timing in the pre- versus post-COVID-19 era

10.1111/irv.70200 · 2025 · External reference

Post-pandemic dynamics of the global circulation of human metapneumovirus and respiratory syncytial virus

10.1093/infdis/jiaf086 · 2025 · External reference

Examining the effect of the COVID-19 pandemic on community virus prevalence and healthcare utilisation reveals that peaks in asthma, COPD and respiratory tract infection occur with the re-emergence of rhino/enterovirus

10.1136/thorax-2022-219957 · 2023 · External reference

Impact of COVID-19 pandemic on asthma exacerbations: retrospective cohort study of over 500,000 patients in a national English primary care database

10.1016/j.lanepe.2022.100428 · 2022 · External reference

Reduction in hospitalised COPD exacerbations during COVID-19: a systematic review and meta-analysis

10.1371/journal.pone.0255659 · 2021 · External reference

Human metapneumovirus seasonality and co-circulation with respiratory syncytial virus: United States, 2014-2024

10.15585/mmwr.mm7411a1 · 2025 · External reference

Resurgence of human metapneumovirus in the post-COVID-19 era: pathogenesis, epidemiological shifts, clinical impact, and future challenges

10.1016/s1473-3099(25)00240-3 · 2025 · External reference

Epidemiological and phylogenetic characteristics of human metapneumovirus in Beijing, China, 2014-2024

10.1038/s41392-025-02377-7 · 2025 · External reference

Human metapneumovirus infection in a cohort of young asymptomatic subjects

2009 · External reference

Detection of respiratory syncytial virus and human metapneumovirus by reverse transcription polymerase chain reaction in adults with and without respiratory illness

10.1016/j.jcv.2005.04.004 · 2006 · External reference

The etiological role of common respiratory viruses in acute respiratory infections in older adults: a systematic review and meta-analysis

10.1093/infdis/jiy662 · 2020 · External reference

Human metapneumovirus (hMPV) in 2025: emerging trends and insights from community and hospital-based respiratory panel analyses; a comprehensive review

10.1186/s12985-025-02782-y · 2025 · External reference

Human metapneumovirus infection in adults and its role in differential diagnosis of COVID-19

10.3390/covid5080137 · 2025 · External reference

Unresolved reference

External reference

Respiratory viral coinfections: interactions, mechanisms and clinical implications

10.1038/s41579-025-01225-3 · 2025 · External reference

Viral interference between respiratory viruses

10.3201/eid2802.211727 · 2022 · External reference

Human respiratory syncytial virus and influenza seasonality patterns: early findings from the WHO global respiratory syncytial virus surveillance

10.1111/irv.12726 · 2020 · External reference

Temporal association between the influenza virus and respiratory syncytial virus (RSV): RSV as a predictor of seasonal influenza

10.1017/s095026881600090x · 2016 · External reference

Viral interference during influenza A–SARS-CoV-2 coinfection of the human airway epithelium and reversal by oseltamivir

10.1093/infdis/jiad402 · 2024 · External reference

Human metapneumovirus-induced host microRNA expression impairs the interferon response in macrophages and epithelial cells

10.3390/v15112272 · 2023 · External reference

Impact and regulation of lambda interferon response in human metapneumovirus infection

10.1128/jvi.02897-14 · 2015 · External reference

Differential responses of pediatric and adult primary epithelial cells to human metapneumovirus and respiratory syncytial virus infection

10.3390/v17030380 · 2025 · External reference

The dual threat: exploring the emergence of human metapneumovirus and SARS-CoV-2 coinfections in respiratory infections

10.1007/s13205-025-04384-5 · 2025 · External reference

The prevalence and role of human metapneumovirus in respiratory tract infections: a systematic review and meta-analysis of global data

10.1016/j.eclinm.2025.103480 · 2025 · External reference

Burden of human metapneumovirus infection in young children

10.1056/nejmoa1204630 · 2013 · External reference

A multi-centre study on epidemiology and clinical characteristics of human metapneumovirus infection in Sri Lanka from 2021 to 2024

10.1099/acmi.0.001022.v3 · 2025 · External reference

Epidemiology of human metapneumovirus-associated lower respiratory tract infections in African children: systematic review and meta-analysis

10.1097/inf.0000000000003041 · 2021 · External reference

Risk factors for pediatric intensive care unit admission in children with human metapneumovirus infections

10.3947/ic.2025.0034 · 2025 · External reference

Hospitalizations due to acute respiratory tract infections caused by human metapneumovirus in Costa Rican children

2025 · External reference

10.1164/ajrccm-conference.2024.209.1_meetingabstracts.a2250

10.1164/ajrccm-conference.2024.209.1_meetingabstracts.a2250 · External reference

Clinical and epidemiological characteristics of human metapneumovirus in children in Hangzhou, China

10.1186/s12985-025-02940-2 · 2025 · External reference

Human metapneumovirus in children with acute lower respiratory infections: effects on clinical and disease severity

10.1186/s12887-025-06101-w · 2025 · External reference

Community-acquired pneumonia requiring hospitalization among U.S. Adults

10.1056/nejmoa1500245 · 2015 · External reference

Clinical and CT characteristics of human metapneumovirus-associated severe pneumonia in children in Beijing

10.1186/s13052-025-01973-1 · 2025 · External reference

Changes in the epidemiology of pneumonia in children younger than 14 years old during and after the COVID-19 pandemic in Mexico, a national multicenter study

10.3390/v18020270 · 2026 · External reference

Management of pediatric pneumonia: a decade after the Pediatric Infectious Diseases Society and Infectious Diseases Society of America guideline

10.1093/cid/ciad385 · 2023 · External reference

The burden of human metapneumovirus (hMPV) disease in older and high-risk adults in developed countries: a systematic literature review

10.1007/s40121-025-01187-2 · 2025 · External reference

The global burden of human metapneumovirus-associated acute respiratory infections in older adults: a systematic review and meta-analysis

10.1016/j.lanhl.2024.100679 · 2025 · External reference

Human metapneumovirus–, respiratory syncytial virus–, and influenza–associated pneumonia hospitalizations in Colorado adults aged ≥50 years, 2016–2023

10.1093/infdis/jiaf381 · 2026 · External reference

Characteristics of human metapneumovirus infection compared to respiratory syncytial virus and influenza infections in adults hospitalized for influenza-like illness in France, 2012-2022

10.1093/infdis/jiaf082 · 2025 · External reference

The impact of respiratory viruses on older adults in long-term care facilities: a scoping review

10.1016/j.cmi.2025.11.002 · 2026 · External reference

Is clinical outcome pathogen related? Characteristics and outcomes of ICU patients with severe acute respiratory infections: focusing on respiratory syncytial virus, human metapneumovirus, influenza virus, and parainfluenza virus

10.1177/08850666251375938 · 2026 · External reference

Clinical characteristics of respiratory syncytial virus and human metapneumovirus pneumonia in adults: a multicenter retrospective cohort study in Japan

10.1016/j.resinv.2026.101392 · 2026 · External reference

Associations between antibiotic use and outcomes in patients hospitalized with community-acquired pneumonia and positive respiratory viral assays

10.1093/cid/ciaf687 · 2026 · External reference

Characteristics and burden of human metapneumovirus infection in older patients: clinico-radiological patterns and impact on survival from a retrospective cohort study

10.1016/j.ijid.2026.108504 · 2026 · External reference

Human metapneumovirus: mechanisms and molecular targets used by the virus to avoid the immune system

10.3389/fimmu.2018.02466 · 2018 · External reference

Human metapneumovirus infections in hematopoietic cell transplant recipients and hematologic malignancy patients: a systematic review

10.1016/j.canlet.2016.05.035 · 2016 · External reference

Mortality rates of human metapneumovirus and respiratory syncytial virus lower respiratory tract infections in hematopoietic cell transplantation recipients

10.1016/j.bbmt.2013.05.005 · 2013 · External reference

Community-acquired respiratory virus infections: a threat to long-term survivors after allogeneic stem cell transplant?

10.1093/cid/ciae602 · 2025 · External reference

Relevance of human metapneumovirus in exacerbations of COPD

10.1186/1465-9921-6-150 · 2005 · External reference

Prevalence of viral infection detected by PCR and RT-PCR in patients with acute exacerbation of COPD: a systematic review

10.1111/j.1440-1843.2010.01722.x · 2010 · External reference

Human metapneumovirus and exacerbations of chronic obstructive pulmonary disease

10.1016/j.jinf.2005.11.010 · 2006 · External reference

Detection of multiple viral and bacterial infections in acute exacerbation of chronic obstructive pulmonary disease: a pilot prospective study

10.1002/jmv.23495 · 2013 · External reference

Human metapneumovirus infection in chronic obstructive pulmonary disease: impact of glucocorticosteroids and interferon

10.1093/infdis/jix167 · 2017 · External reference

Advances in laboratory assays for detecting human metapneumovirus

10.21037/atm.2019.12.42 · 2020 · External reference

Laboratory testing for respiratory viruses for the clinician

10.3949/ccjm.91.s1.07 · 2024 · External reference

Nasopharyngeal viral PCR in immunosuppressed patients and its association with virus detection in bronchoalveolar lavage by PCR

10.1111/resp.13049 · 2017 · External reference

Diagnosis and treatment of adults with community-acquired pneumonia: an official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America

10.1164/rccm.201908-1581st · 2019 · External reference

Human metapneumovirus: pathogenesis, epidemiology, diagnostic technologies, and potential intervention strategies

10.1186/s12985-025-02983-5 · 2025 · External reference

Nucleic acid-based testing for noninfluenza viral pathogens in adults with suspected community-acquired pneumonia: an official American Thoracic Society clinical practice guideline

10.1164/rccm.202102-0498st · 2021 · External reference

Respiratory viral testing and antibacterial treatment in patients hospitalized with community-acquired pneumonia

10.1017/ice.2020.1312 · 2021 · External reference

Impact of respiratory viruses detection on outcomes in ventilated nosocomial pneumonia: an exposed/unexposed study

10.1186/s13613-025-01600-6 · 2025 · External reference

Impact of respiratory viruses in hospital-acquired pneumonia in the intensive care unit: a single-center retrospective study

10.1016/j.jcv.2017.04.001 · 2017 · External reference

Severe respiratory failure due to co-infection with human metapneumovirus and Streptococcus pneumoniae

10.1016/j.rmcr.2013.12.007 · 2014 · External reference

Metagenomic analysis of viral nucleic acid extraction methods in respiratory clinical samples

10.1186/s12864-018-5152-5 · 2018 · External reference

Microbiologic diagnosis of respiratory infections in critically ill immunocompromised patients

10.1055/a-2808-5317 · 2026 · External reference

Preventing respiratory viral transmission in healthcare settings

10.1097/qco.0000000000001115 · 2025 · External reference

10.1371/journal.ppat.1013312 · 2025 · Admitted local publication

Evaluation of a live attenuated human metapneumovirus vaccine in adults and children

10.1093/jpids/pix006 · 2018 · External reference

Metavac-RSV mucosal bivalent vaccine candidate protects cotton rats against pneumoviruses and is produced using serum-free cell culture in bioreactor

10.1038/s41541-025-01231-9 · 2025 · External reference

A randomized phase 1 clinical trial of a respiratory syncytial virus and human metapneumovirus combination protein-based virus-like particle vaccine in adults 60-75 years of age

10.1093/ofid/ofaf160 · 2025 · External reference

P-601. Safety and immunogenicity of a respiratory syncytial virus and human metapneumovirus virus-like particle protein subunit combination vaccine in 60- to 85-year-old adults: interim results from a phase 2a clinical trial

10.1093/ofid/ofae631.799 · 2025 · External reference

A pan-pneumovirus vaccine based on immunodominant epitopes of the fusion protein

10.3389/fimmu.2022.941865 · 2022 · External reference

Safety and immunogenicity of an mRNA-based human metapneumovirus and parainfluenza virus type 3 combined vaccine in healthy adults

10.1093/ofid/ofac206 · 2022 · External reference

Safety and immunogenicity of an mRNA-based hMPV/PIV3 combination vaccine in seropositive children

10.1542/peds.2023-064748 · 2024 · External reference

FDA pauses all infant RSV vaccine trials after rise in severe illnesses

10.1136/bmj.q2852 · 2024 · External reference